CK2 also stimulates the canonical Wnt pathway in colon cancer, where it phosphorylates and stabilizes β-catenin, which promotes expression of key proteins involved in tumor progression, such as survivin, c-myc, COX-2 and endothelin-1 [18–21]. This evidence concerns the gene BIRC5 and malignant colon neoplasm.